Posted by Michael Wonder on 21 Jun 2021
EMA publishes agenda for 21-24 June CHMP meeting
21 June 2021 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Idecabtagene vicleucel
- Abiraterone acetate
- Bimekizumab
- Ranibizumab
- Roxadustat
- Eflornithine with sulindac
- Tafasitamab
